Back to Search
Start Over
Decreased mRNA expression of GATA1 and GATA2 is associated with tumor aggressiveness and poor outcome in clear cell renal cell carcinoma
- Source :
- Targeted oncology. 10(2)
- Publication Year :
- 2014
-
Abstract
- GATA-binding proteins 1 (GATA1) and 2 (GATA2) are zinc-finger transcription factors and belong to the GATA family proteins 1–6. GATA1 interacts with the TP53 tumor suppressor gene, and both GATAs have been shown to be involved in cell growth, apoptosis, and tumorigenesis of several solid tumors. GATA1 and GATA2 expression alterations are associated with poor survival and adverse clinicopathology in prostate and colorectal cancer, while the significance and prognostic value in clear cell renal cell carcinoma (ccRCC) has not been investigated as yet. We investigated relative messenger RNA (mRNA) expression levels of GATA1 and GATA2 in 77 ccRCC and 58 paired adjacent noncancerous renal tissues by quantitative real-time reverse-transcribed PCR. Relative mRNA expression levels were determined using the ΔΔCt method. GATA1 and GATA2 expression levels were significantly decreased in tumor tissues compared with normal tissues (p
- Subjects :
- Male
Cancer Research
Time Factors
Tumor suppressor gene
Colorectal cancer
Down-Regulation
Kaplan-Meier Estimate
medicine.disease_cause
Real-Time Polymerase Chain Reaction
Disease-Free Survival
Renal cell carcinoma
Risk Factors
medicine
Carcinoma
Biomarkers, Tumor
Humans
Pharmacology (medical)
GATA1 Transcription Factor
RNA, Messenger
Carcinoma, Renal Cell
Proportional Hazards Models
Retrospective Studies
business.industry
Reverse Transcriptase Polymerase Chain Reaction
GATA2
Middle Aged
medicine.disease
Kidney Neoplasms
GATA2 Transcription Factor
Gene Expression Regulation, Neoplastic
Clear cell renal cell carcinoma
Real-time polymerase chain reaction
Cross-Sectional Studies
Oncology
Lymphatic Metastasis
Cancer research
Female
business
Carcinogenesis
Subjects
Details
- ISSN :
- 1776260X
- Volume :
- 10
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- Targeted oncology
- Accession number :
- edsair.doi.dedup.....33d2c0b1598d62ac6d21eeef7feb93f4